Genenta Science S.p.A.
About Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $48.1M
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $48.1M
- Shares outstanding
- 26.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 15, 2021
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Trading 71% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Genenta Science S.p.A..
Write a review
News about Genenta Science S.p.A.
News & sentiment via Polygon.io
